Mushroom supplement tested to ease chemo side effects in lung cancer patients
NCT ID NCT07241182
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a supplement made from the Antrodia cinnamomea mushroom can improve quality of life for people with lung cancer who are receiving platinum-based chemotherapy. About 40 participants will take either the supplement or a placebo for 3 months, and researchers will track nausea, vomiting, sleep quality, and other symptoms. The goal is to see if this natural extract can help reduce common chemotherapy side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tri-Service General Hospital
RECRUITINGTaipei, 114, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Common mucus-thinning drugs may improve outcomes in COPD patients with lung cancer
- Can a simple blood test predict leukemia risk after cancer therapy?
- AI could help doctors diagnose lung cancer faster during a bronchoscopy
- New imaging registry aims to sharpen cancer treatment precision
- Blood test may spot lung cancer early, avoiding unnecessary biopsies
- Lung cancer Follow-Up: is Twice-Yearly CT better than once a year?